Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

Fig. 5

Quality of life (QOL) a Comparison of patients’ QOL between the mesenchymal stem cell (MSC) and placebo groups based on the Diabetes specific QOL (DQOL) and 36-Item Short Form Survey (SF-36) questionnaires. The left Y-axis represents the mean in each group drawn by column charts, and the right Y-axis belongs to the mean differences compared to the baseline drawn by scatter plots. There were no significant changes reported. Error bars represent the standard deviation for bar charts and the standard error of the mean for scatter plots. b Comparison of patients’ QOL between early (Early Tx) and late (Late Tx) transplantation of MSCs based on the DQOL and SF-36 questionnaires. The left Y-axis represents the mean in each group drawn by column charts, and the right Y-axis belongs to the mean differences compared to the baseline drawn by scatter plots. Error bars represent the standard deviation for bar charts and the standard error of the mean for scatter plots. *P < 0.05

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512